ReproCell Inc
TSE:4978
ReproCell Inc
TSE:4978
Price:
135 JPY
-0.74%
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
ReproCell Inc
stock under the Base Case scenario is
247.26
JPY.
Compared to the current market price of 135 JPY,
ReproCell Inc
is
Undervalued by 45%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
247.26
JPY
Undervaluation 45%
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
ReproCell Inc Competitors
ReproCell Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
ReproCell Inc
TSE:4978
|
11.5B JPY | 4.6 | -52.8 | -13 | -11.7 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
280.4B USD | 5.2 | 58.2 | 12.7 | 19.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
146.3B USD | 5.2 | 21.7 | 16.2 | 24.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
102.4B USD | 10.3 | 28.2 | 22.6 | 23.7 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
97.9B USD | 7.5 | 24.8 | 16.4 | 18 | |
| AU |
|
CSL Ltd
ASX:CSL
|
132.9B AUD | 6.1 | 35.1 | 21.3 | 26.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
82.8B USD | 3.1 | 14.6 | 8 | 10.3 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
42.6B USD | 6.2 | -9 | -9.6 | -8.2 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
31.6B USD | 3.2 | 27.2 | 14.7 | 18.2 | |
| IE |
|
Horizon Therapeutics PLC
NASDAQ:HZNP
|
26.6B USD | 7.3 | 60.8 | 27.9 | 47 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
